Melatonin-mediated Bim up-regulation and cyclooxygenase-2 (COX-2) down-regulation enhances tunicamycin-induced apoptosis in MDA-MB-231 cells

Journal of Pineal Research

Volumn 58, Issue 3, 2015, Pages 310-320

  Woo, Seon Min ^a   Min, Kyoung Jin ^a   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

Author keywords

apoptosis; COX 2; melatonin; NF B; p38 MAPK; tunicamycin

Indexed keywords

BIM PROTEIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 14; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PERTUSSIS TOXIN; TUNICAMYCIN; APOPTOSIS REGULATORY PROTEIN; BCL-2-LIKE PROTEIN 11; MEMBRANE PROTEIN; ONCOPROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELATONIN; MEMBRANE PROTEINS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TUNICAMYCIN; UP-REGULATION;

EID: 84924658832     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12217     Document Type: Article

References (53)

1. Reiter RJ, Tan DX, Galano A,. Melatonin: exceeding expectations. Physiology (Bethesda) 2014; 29: 325-333.
2. Hardeland R, Madrid JA, Tan DX, et al. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012; 52: 139-166.
3. Reiter RJ, Tan DX, Terron MP, et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1-9.
4. Kuesel JT, Hardeland R, Pfoertner H, et al. Reactions of the melatonin metabolite N(1)-acetyl-5-methoxykynuramine with carbamoyl phosphate and related compounds. J Pineal Res 2010; 48: 47-54.
5. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
6. Wang J, Xiao X, Zhang Y, et al. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res 2012; 53: 77-90.
7. Uguz AC, Cig B, Espino J, et al. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 2012; 53: 91-98.
8. Proietti S, Cucina A, Dobrowolny G, et al. Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells. J Pineal Res 2014; 57: 120-129.
9. Cos S, Gonzalez A, Martinez-Campa C, et al. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006; 30: 118-128.
10. Bejarano I, Redondo PC, Espino J, et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46: 392-400.
11. Jung-Hynes B, Reiter RJ, Ahmad N,. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19.
12. Leja-Szpak A, Jaworek J, Pierzchalski P, et al. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 49: 248-255.
13. Cui P, Yu M, Peng X, et al. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res 2012; 52: 236-243.
14. Kim KJ, Choi JS, Kang I, et al. Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model. J Pineal Res 2013; 54: 264-270.
15. Swarnakar S, Paul S, Singh LP, et al. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res 2011; 50: 8-20.
16. Mahoney WC, Duksin D,. Biological activities of the two major components of tunicamycin. J Biol Chem 1979; 254: 6572-6576.
17. Olden K, Pratt RM, Jaworski C, et al. Evidence for role of glycoprotein carbohydrates in membrane transport: specific inhibition by tunicamycin. Proc Natl Acad Sci USA 1979; 76: 791-795.
18. Rasheed Z, Haqqi TM,. Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2alpha, p38-MAPK and NF-kappaB in advanced glycation end products stimulated human chondrocytes. Biochim Biophys Acta 2012; 1823: 2179-2189.
19. Hung JH, Su IJ, Lei HY, et al. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem 2004; 279: 46384-46392.
20. Patel VA, Dunn MJ, Sorokin A,. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 2002; 277: 38915-38920.
21. Howe LR,. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 2007; 9: 210-219.
22. Liu B, Qu L, Tao H,. Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance. Cell Biol Int 2010; 34: 21-25.
23. Bouillet P, Zhang LC, Huang DC, et al. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 2001; 12: 163-168.
24. Brattstrom D, Wester K, Bergqvist M, et al. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. Acta Oncol 2004; 43: 80-86.
25. Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function. FASEB J 2010; 24: 3603-3624.
26. Mendez-Samperio P, Perez A, Trejo A,. Sphingosine kinase, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 are required for CCL5 production in Mycobacterium bovis Bacillus Calmette-Guerin (BCG)-infected epithelial cells. Cell Immunol 2007; 249: 94-100.
27. Thompson WL, Van Eldik LJ,. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res 2009; 1287: 47-57.
28. Rodriguez MS, Thompson J, Hay RT, et al. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J Biol Chem 1999; 274: 9108-9115.
29. Ferreiro DU, Komives EA,. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry 2010; 49: 1560-1567.
30. Dean JL, Brook M, Clark AR, et al. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999; 274: 264-269.
31. Farriol M, Venereo Y, Orta X, et al. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line. J Appl Toxicol 2000; 20: 21-24.
32. Papazisis KT, Kouretas D, Geromichalos GD, et al. Effects of melatonin on proliferation of cancer cell lines. J Pineal Res 1998; 25: 211-218.
33. Petranka J, Baldwin W, Biermann J, et al. The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 1999; 26: 129-136.
34. Mao L, Cheng Q, Guardiola-Lemaitre B, et al. In vitro and in vivo antitumor activity of melatonin receptor agonists. J Pineal Res 2010; 49: 210-221.
35. Hill SM, Spriggs LL, Simon MA, et al. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992; 64: 249-256.
36. Mao L, Yuan L, Xiang S, et al. Molecular deficiency (ies) in MT(1) melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells. J Pineal Res 2014; 56: 246-253.
37. Wiesenberg I, Missbach M, Carlberg C,. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998; 12: 143-150.
38. Schroder M,. Endoplasmic reticulum stress responses. Cell Mol Life Sci 2008; 65: 862-894.
39. Yang L, Carlson SG, McBurney D, et al. Multiple signals induce endoplasmic reticulum stress in both primary and immortalized chondrocytes resulting in loss of differentiation, impaired cell growth, and apoptosis. J Biol Chem 2005; 280: 31156-31165.
40. Khan Z, Khan N, Tiwari RP, et al. Biology of Cox-2: an application in cancer therapeutics. Curr Drug Targets 2011; 12: 1082-1093.
41. Zha L, Fan L, Sun G, et al. Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res 2012; 52: 322-331.
42. Srinivasan V, Pandi-Perumal SR, Spence DW, et al. Melatonin in septic shock: some recent concepts. J Crit Care 2010; 25: 656 e1-6.
43. Yuan L, Collins AR, Dai J, et al. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002; 192: 147-156.
44. Lai L, Yuan L, Cheng Q, et al. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat 2009; 118: 293-305.
45. Fan L, Sun G, Ma T, et al. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin. J Pineal Res 2013; 55: 184-194.
46. Kim HS, Kim TJ, Yoo YM,. Melatonin combined with endoplasmic reticulum stress induces cell death via the PI3K/Akt/mTOR pathway in B16F10 melanoma cells. PLoS ONE 2014; 9: e92627.
47. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999; 18: 6013-6020.
48. Hetz C,. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012; 13: 89-102.
49. Kaneko M, Niinuma Y, Nomura Y,. Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol Pharm Bull 2003; 26: 931-935.
50. Jiang HY, Wek SA, McGrath BC, et al. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol 2003; 23: 5651-5663.
51. Min KJ, Jang JH, Kwon TK,. Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of Akt-induced NF-kappaB and STAT/GAS activity. J Pineal Res 2012; 52: 296-304.
52. Faber AC, Ebi H, Costa C, et al. Apoptosis in targeted therapy responses: the role of BIM. Adv Pharmacol 2012; 65: 519-542.
53. Wang YM, Jin BZ, Ai F, et al. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol 2012; 69: 1213-1220.